AMY LABRON: Open Payments
NPI 1912335811 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 19 payments from 10 companies in 2025. Trend: 2023 $273 · 2024 $247 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $128 |
| Merz Pharmaceuticals, LLC | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $62 |
| Averitas Pharma Inc. | 3 | $58 |
| IBSA Pharma Inc. | 2 | $45 |
| Saluda Medical Americas, Inc. | 2 | $38 |
| Coastal Medical Technologies LLC | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Globus Medical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: PROCLAIM, Xeomin, XTAMPZA, QUTENZA, Tirosint, Evoke, JOURNAVX, Senza.
Industry payments across FL — which companies pay providers there.
